Cadrenal Therapeutics, Inc. (CVKD) Ownership
CVKD ownership summary
as of October 17, 2026- Institutions
- 10.9% of shares outstanding
- Insiders
- 9.66% of shares outstanding
- Shares outstanding
- 3.1M
- Float
- 3.2M shares available to trade
- Short interest
- 3.31% 106K shares short
- Days to cover
- 0.09 short interest down 10.8% vs prior month
- Institutions 10.91%
- Insiders 9.66%
- Other investors 79.43%
CVKD top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management, LLC | 1.41% | 50K | $54,649 | +4,936 (+10.9%) | June 30, 2026 |
| 2 | HRT FINANCIAL LLC | 0.81% | 29K | $31,670 | +29,055 (0.0%) | June 30, 2026 |
| 3 | Geode Capital Management, LLC | 0.53% | 19K | $20,736 | −2,602 (−12.0%) | June 30, 2026 |
| 4 | Vanguard Fiduciary Trust Co | 0.23% | 8,311 | $9,059 | — | June 30, 2026 |
| 5 | Tower Research Capital LLC | 0.04% | 1,282 | $1,397 | +889 (+226.2%) | June 30, 2026 |
| 6 | UBS Group AG | 0.03% | 1,112 | $1,212 | +1,109 (+36,966.7%) | June 30, 2026 |
| 7 | Coconut Grove Bank | 0.03% | 1,000 | $1,090 | +1,000 (0.0%) | June 30, 2026 |
| 8 | Morgan Stanley - Brokerage Accounts | 0.02% | 706 | $770 | +606 (+606.0%) | June 30, 2026 |
| 9 | Hartland & Co | 0.02% | 650 | $708 | +650 (0.0%) | June 30, 2026 |
| 10 | Quest 10 Wealth Builders, Inc. | 0.01% | 380 | $414 | +380 (0.0%) | June 30, 2026 |
| 11 | Advisor Group Holdings, Inc. | 0.01% | 300 | $327 | — | June 30, 2026 |
| 12 | Rockefeller Capital Management L.P. | <0.01% | 150 | $164 | — | June 30, 2026 |
| 13 | Wells Fargo & Co | <0.01% | 99 | $108 | — | June 30, 2026 |
| 14 | Barclays PLC | <0.01% | 93 | $101 | +93 (0.0%) | June 30, 2026 |
| 15 | Integrated Wealth Concepts LLC | <0.01% | 86 | $94 | +86 (0.0%) | June 30, 2026 |
| 16 | Archer Investment Corporation | <0.01% | 70 | $76 | +35 (+100.0%) | June 30, 2026 |
| 17 | IFP Advisors, LLC | <0.01% | 30 | $33 | — | June 30, 2026 |
| 18 | BlackRock Inc | 0.00% | — | — | −5,496 (−100.0%) | June 30, 2026 |
| 19 | CURIO WEALTH, LLC | 0.00% | — | — | −1 (−100.0%) | June 30, 2026 |
| 20 | HARBOUR INVESTMENTS, INC. | 0.00% | — | — | −100 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 39K shares and 4 cut 8,199.
CVKD top mutual fund and ETF holders
7 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 0.93% | 33K | $36,273 | — | August 31, 2026 |
| 2 | Abante Quant Value FI | 0.36% | 13K | $14,114 | — | August 31, 2026 |
| 3 | Fidelity Extended Market Index | 0.34% | 12K | $13,343 | −66 (−0.5%) | August 31, 2026 |
| 4 | Fidelity Series Total Market Index | 0.07% | 2,449 | $2,669 | — | August 31, 2026 |
| 5 | Fidelity Nasdaq Composite Index | 0.06% | 2,041 | $2,225 | — | August 31, 2026 |
| 6 | Fidelity Total Market Index | 0.03% | 1,109 | $1,209 | — | August 31, 2026 |
| 7 | Dimensional US Sustainability Core 1 ETF | 0.03% | 914 | $996 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CVKD insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-29 | Matthew K Szot | Sell | $6.97 | 9,933 | $69,233 |
| 2025-10-27 | Matthew K Szot | Sell | $13.99 | 1,800 | $25,182 |
| 2025-10-27 | Quang X Pham | Sell | $13.99 | 1,315 | $18,397 |
| 2025-10-24 | Matthew K Szot | Sell | $13.99 | 1,800 | $25,182 |
| 2025-10-24 | Quang X Pham | Sell | $14.03 | 1,129 | $15,840 |
| 2025-10-13 | Matthew K Szot | Sell | $14.07 | 1,800 | $25,326 |
| 2025-10-13 | Quang X Pham | Sell | $14.15 | 1,800 | $25,470 |
| 2025-10-09 | Matthew K Szot | Sell | $13.99 | 1,693 | $23,685 |
| 2025-10-09 | Quang X Pham | Sell | $14.02 | 1,800 | $25,236 |
| 2025-10-06 | Matthew K Szot | Sell | $13.99 | 107 | $1,497 |
| 2025-10-02 | Quang X Pham | Sell | $14.13 | 500 | $7,065 |
| 2025-10-01 | Matthew K Szot | Sell | $13.99 | 1,700 | $23,783 |
| 2025-10-01 | Quang X Pham | Sell | $14.01 | 881 | $12,343 |
| 2025-09-29 | Matthew K Szot | Sell | $14.00 | 100 | $1,400 |
| 2025-09-29 | Quang X Pham | Sell | $14.01 | 419 | $5,870 |
| 2025-09-25 | Matthew K Szot | Sell | $14.05 | 10,900 | $153,145 |
| 2025-09-25 | Quang X Pham | Sell | $14.09 | 6,790 | $95,671 |
| 2025-09-24 | Matthew K Szot | Sell | $14.00 | 1,500 | $21,000 |
| 2025-09-24 | Quang X Pham | Sell | $13.99 | 2,581 | $36,108 |
| 2025-08-28 | Matthew K Szot | Sell | $14.00 | 400 | $5,600 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CVKD shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CVKD
Institutional investors own 10.9% of Cadrenal Therapeutics's shares and insiders 9.66%. The largest holder is Vanguard Capital Management, LLC with 1.41% of the shares (50K), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 4 reduced their stake in the latest filings. Short interest is 3.31% of the float, or 0.09 days of average trading volume. The share count rose 157.1% since 2022.
Related: CVKD analyst forecast, CVKD key metrics. See the CVKD stock overview for the latest quote and news.
CVKD ownership FAQ
Who owns the most Cadrenal Therapeutics stock?
The largest shareholders of Cadrenal Therapeutics are Vanguard Capital Management, LLC (1.41%), HRT FINANCIAL LLC (0.81%), Geode Capital Management, LLC (0.53%), Vanguard Fiduciary Trust Co (0.23%), Tower Research Capital LLC (0.04%).
What percentage of Cadrenal Therapeutics is owned by institutions?
Institutions hold 10.9% of Cadrenal Therapeutics's shares outstanding; insiders hold 9.66%.
Which funds own Cadrenal Therapeutics?
The largest fund holders of Cadrenal Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (0.93%), Abante Quant Value FI (0.36%), Fidelity Extended Market Index (0.34%), Fidelity Series Total Market Index (0.07%), Fidelity Nasdaq Composite Index (0.06%).
What is Cadrenal Therapeutics's short interest?
106K shares of Cadrenal Therapeutics were sold short, 3.31% of the float; at the average daily volume it would take 0.09 days to cover.
Are insiders buying or selling Cadrenal Therapeutics?
Of the latest 20 reported insider transactions in Cadrenal Therapeutics (since August 28, 2025), 0 were purchases and 20 were sales.
How many shares of Cadrenal Therapeutics are outstanding?
Cadrenal Therapeutics has 3.1M shares outstanding, of which 3.2M are in the public float.